tiprankstipranks
Trending News
More News >
Immutep announces response rates from INSIGHT-003 trial
PremiumThe FlyImmutep announces response rates from INSIGHT-003 trial
2M ago
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
Premium
Company Announcements
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Immutep Advances Cancer Trials with Promising Developments
PremiumCompany AnnouncementsImmutep Advances Cancer Trials with Promising Developments
2M ago
Immutep Advances in NSCLC Treatment with TACTI-004 Trial
Premium
Company Announcements
Immutep Advances in NSCLC Treatment with TACTI-004 Trial
2M ago
Immutep Director Increases Stake Through Performance Rights Exercise
Premium
Company Announcements
Immutep Director Increases Stake Through Performance Rights Exercise
3M ago
Immutep announces first patient dosed in TACTI-004 Phase III trial
PremiumThe FlyImmutep announces first patient dosed in TACTI-004 Phase III trial
3M ago
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
Premium
Company Announcements
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
3M ago
Immutep announces poster presentation for the TACTI-004 Phase III trial
Premium
The Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100